CTMXCytomX Therapeutics, Inc.
$2.19-48% 1Y
$2.19
$2.1252 weeks$6.75
The share price
How CTMX is trading
CytomX Therapeutics, Inc. is −48% over the past year while the S&P 500 is +9.2%: 57 points behind the market.
−48%
1-year return · S&P 500 +9.2%
- vs 200-day average
- −42%
vs 200-day average · more than 10% below its 200-day average
- RSI (14)
- 45
RSI (14) · between 30 and 70 on a 0 to 100 scale
- Below its 52-week high
- 68%
Below its 52-week high
Details›
- Last close2026-11-06
- $2.19
- 1 monthS&P 500 −4.9%
- −11%
- 1 yearS&P 500 +9.2%
- −48%
- 5 yearsS&P 500 +72%
- −63%
- vs 50-day average$2.71
- −19%
- 52-week high
- $6.75
- 52-week low
- $2.12
- Annualised volatility
- 129%
- Insider selling, net, 6 monthsForms 3/4/5 to 2026-11-05
- $5K
Calendar-year price return
| Year | Return |
|---|---|
| 2017 | +92% |
| 2018 | −28% |
| 2019 | −45% |
| 2020 | −21% |
| 2021 | −34% |
| 2022 | −63% |
| 2023 | −3.1% |
| 2024 | −34% |
| 2025 | +314% |
| 2026 YTD | −49% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 7 of 10 | +13% |
| Feb | 10 | 4 of 10 | −1.4% |
| Mar | 10 | 2 of 10 | −4.7% |
| Apr | 10 | 4 of 10 | −1.9% |
| May | 10 | 4 of 10 | +20% |
| Jun | 10 | 5 of 10 | −2.7% |
| Jul | 11 | 3 of 11 | −6.0% |
| Aug | 11 | 5 of 11 | −0.77% |
| Sep | 11 | 3 of 11 | +1.5% |
| Oct | 11 | 3 of 11 | −7.6% |
| Nov | 11 | 8 of 11 | +9.5% |
| Dec | 10 | 4 of 10 | −0.44% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
Its returns year by year and month by month, with dividends where it pays them.
Biotechnology
The closest names by size in the same industry